Insider Trading & Ownership - Langren Carl W.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Langren Carl W.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-04-01
Tax Withholding
2021-04-05
5:47 pm
N/A
N/A
LUMOS PHARMA INC.LUMOLangren Carl W.
Chief Financial Officer
683$12.2517,015
(Direct)
View
2021-02-01
Option Award
2021-02-03
6:51 pm
N/A
2031-01-31
LUMOS PHARMA INC.LUMOLangren Carl W.
Chief Financial Officer
12,414$029,173
(Direct)
View
2020-04-01
Option Award
2020-04-03
6:22 pm
N/A
2030-03-31
LUMOS PHARMA INC.LUMOLangren Carl W.
Chief Financial Officer
54,000$061,759
(Direct)
View
2020-01-04
Tax Withholding
2020-01-06
8:09 pm
N/A
N/A
NEWLINK GENETICS CORPNLNKLangren Carl W.
Chief Financial Officer
281$2.2169,835
(Direct)
View
2019-07-31
Disposition
2019-08-02
6:38 pm
N/A
2027-01-02
NEWLINK GENETICS CORPNLNKLangren Carl W.
Chief Financial Officer
192,500$096,253
(Direct)
View
2019-07-31
Option Award
2019-08-02
6:38 pm
N/A
2026-07-31
NEWLINK GENETICS CORPNLNKLangren Carl W.
Chief Financial Officer
96,253$096,253
(Direct)
View
2019-07-31
Disposition
2019-08-02
6:38 pm
2011-03-03
2020-03-02
NEWLINK GENETICS CORPNLNKLangren Carl W.
Chief Financial Officer
150,144$060,921
(Direct)
View
2019-07-31
Option Award
2019-08-02
6:38 pm
N/A
2026-07-31
NEWLINK GENETICS CORPNLNKLangren Carl W.
Chief Financial Officer
60,921$060,921
(Direct)
View